Tech Company Financing Transactions

Paragon Bioservices Funding Round

Private investors participated in a $2 million Series A venture round for Paragon Bioservices. The round was announced on 8/18/2015.

Transaction Overview

Announced On
8/18/2015
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
801 W. Baltimore St. 302
Baltimore, MD 21201
USA
Email Address
Not Recorded
Overview
Highly-flexible and responsive, we work in partnership with our clients to ensure efficient and cost-effective preclinical target validation services, process development and scale-up production of biopharmaceuticals for research purposes or Phase I/II clinical trials.
Profile
Paragon Bioservices LinkedIn Company Profile
Social Media
Paragon Bioservices Company Twitter Account
Company News
Paragon Bioservices News
Facebook
Paragon Bioservices on Facebook
YouTube
Paragon Bioservices on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Peter Buzy
  Peter Buzy LinkedIn Profile  Peter Buzy Twitter Account  Peter Buzy News  Peter Buzy on Facebook
Chief Financial Officer
Gerard Fleury
  Gerard Fleury LinkedIn Profile  Gerard Fleury Twitter Account  Gerard Fleury News  Gerard Fleury on Facebook
Chief Information Officer
Dermot McCaul
  Dermot McCaul LinkedIn Profile  Dermot McCaul Twitter Account  Dermot McCaul News  Dermot McCaul on Facebook
Chief Scientific Officer
William Thomas
  William Thomas LinkedIn Profile  William Thomas Twitter Account  William Thomas News  William Thomas on Facebook
Vice President
George Buchman
  George Buchman LinkedIn Profile  George Buchman Twitter Account  George Buchman News  George Buchman on Facebook
VP - Bus. Development
Philip Wills
  Philip Wills LinkedIn Profile  Philip Wills Twitter Account  Philip Wills News  Philip Wills on Facebook
VP - Finance
Anne Shiflett
  Anne Shiflett LinkedIn Profile  Anne Shiflett Twitter Account  Anne Shiflett News  Anne Shiflett on Facebook
VP - Human Resources
Ruby Hofmann
  Ruby Hofmann LinkedIn Profile  Ruby Hofmann Twitter Account  Ruby Hofmann News  Ruby Hofmann on Facebook
VP - Manufacturing
John Conner
  John Conner LinkedIn Profile  John Conner Twitter Account  John Conner News  John Conner on Facebook
VP - Manufacturing
Randy Henrickson
  Randy Henrickson LinkedIn Profile  Randy Henrickson Twitter Account  Randy Henrickson News  Randy Henrickson on Facebook
VP - Regulatory Affairs
Deborah Wild
  Deborah Wild LinkedIn Profile  Deborah Wild Twitter Account  Deborah Wild News  Deborah Wild on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/18/2015: HzO venture capital transaction
Next: 8/18/2015: Cignifi venture capital transaction

 

Share this article

 


About Database of VC Transactions

Our team works diligently to report on all VC transactions involving tech companies. VC transactions on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary